stockrow
Saturday 7 November 2026
Export SCNX’s income statement to Excel — free account
Scienture Holdings, Inc.
SCNX Healthcare Pharmaceutical Retailers
Scienture Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $431,600.00, up 216.0% from fiscal 2024.
- Revenue
- +3,235.9%
- EPS
- +85.4%
- Free cash flow
- −54.0%
- Total debt
- +831.4%
Quarter to June 2026, against a year earlier
3.13
0.03
+0.97%
Follow SCNX
Alert me
Scienture Holdings, Inc. (SCNX) P/E ratio
Scienture Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 3,608× (October 2019) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 2.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 1,071× | 2,051.68% |
| FY2017 | 49.8× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 40 more quarters | Free account |
Against its own ten years
Low 0.0×
High 3,608×
Ten-year median
0.0×
Current reading's percentile
79
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SCNX Scienture Holdings, Inc. | n/m |
| RDGT Ridgetech Inc. compare | n/m |
| PETS PetMed Express, Inc. compare | n/m |
| HITI High Tide Inc. compare | n/m |
| POM Pomdoctor Limited - Sponsored ADR compare | — |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)